Novartis, Armed With New IP, Again Sues Over $3B MS Drug
By Dani Kass · January 29, 2020, 3:23 PM EST
Immediately after Novartis was granted a new patent Tuesday, the pharma giant sued a large group of generic-drug makers hoping to block their competing versions of its $3 billion multiple sclerosis...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login